Subscriber access provided by Iowa State University | Library
Article
N-hydroxysulfosuccinimide esters versus thiomers: a comparative study regarding mucoadhesiveness Christina Leichner, Patrizia Wulz, Randi Angela Baus, Claudia Menzel, Sina Katharina Götzfried, Ronald Gust, and Andreas Bernkop-Schnürch Mol. Pharmaceutics, Just Accepted Manuscript • DOI: 10.1021/acs.molpharmaceut.8b01183 • Publication Date (Web): 01 Feb 2019 Downloaded from http://pubs.acs.org on February 5, 2019
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
1
N-hydroxysulfosuccinimide esters versus thiomers: a comparative study regarding
2
mucoadhesiveness
3 4
Christina Leichner1, Patrizia Wulz1, Randi Angela Baus1, Claudia Menzel1, Sina Katharina Götzfried2,
5
Ronald Gust2 and Andreas Bernkop-Schnürch1*
6 7
1Center
for Chemistry and Biomedicine,
8
Department of Pharmaceutical Technology,
9
Institute of Pharmacy, University of Innsbruck,
10
Innrain 80/82, 6020 Innsbruck, Austria
11 12
2Center
for Chemistry and Biomedicine,
13
Department of Pharmaceutical Chemistry,
14
Institute of Pharmacy, University of Innsbruck,
15
Innrain 80/82, 6020 Innsbruck, Austria
16 17
*Corresponding Author:
18
Center for Chemistry and Biomedicine,
19
Department of Pharmaceutical Technology,
20
Institute of Pharmacy, University of Innsbruck,
21
Innrain 80/82, 6020 Innsbruck, Austria
22
Tel.: +43-512-507 58601
23
Fax: +43-512-507 58699
24
e-mail:
[email protected] 25
ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 2 of 39
26
Abstract
27
AIM: The objective of the study was to compare polyacrylic acid-N-hydroxysulfosuccinimide
28
reactive esters (PAA-Sulfo-NHS) and polyacrylic acid-cysteine conjugates (PAA-Cys) regarding
29
their mucoadhesiveness.
30
METHODS: Polymer conjugates were synthesized in a water free environment and characterized
31
by UV/VIS spectroscopy and FTIR. Water uptake studies were performed and the polymers were
32
further examined for their mucoadhesive properties and cohesiveness using the rotating cylinder
33
method. Tensile force measurements were conducted to define the strength of adhesion to porcine
34
intestinal mucosa. Additionally, polymer-mucus mixtures were assessed for rheological synergism
35
by measuring the increase in dynamic viscosity.
36
RESULTS: Both modifications led to a prolonged adhesion time compared to unmodified PAA.
37
Fast dissolution of PAA-Sulfo-NHS derivatives was monitored, whereas PAA-Cys tends to
38
extensively swell while exhibiting high cohesive properties. Measurements of tensile force
39
revealed up to 2.7-fold (PAA-Sulfo-NHS) and 2.3-fold (PAA-Cys) enhancement of the maximum
40
detachment force and 7.6-fold (PAA-Sulfo-NHS) and 3.6-fold (PAA-Cys) increase in the total
41
work of adhesion. Formation of a gel network between polymer and mucus was confirmed by a
42
10.8-fold (PAA-Sulfo-NHS) and 20.8-fold (PAA-Cys) increase in viscosity.
43
CONCLUSION: Both types of polymers show high mucoadhesive properties due to the formation
44
of covalent bonds with the mucus. As thiolated polymers are capable of forming stabilizing
45
disulfide bonds within their polymeric network, they are advantageous over PAA-Sulfo-NHS.
46
Key words: Polyacrylic acid, Sulfo-NHS ester, thiomer, mucoadhesion, amino reactive ester
47
1. Introduction 2 ACS Paragon Plus Environment
Page 3 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
48
Availability of the drug at its desired target location is often limited by the short contact time
49
between the absorption membrane and the formulation. Especially in the small intestine where
50
motility activity is high and transit is fast it is challenging to concentrate the drug at the site of
51
action. A promising, and already over years well-established strategy to elongate the residence of
52
the delivery system at the mucosal surface comprises the application of mucoadhesive polymers
53
(1-5). Thereby, a high local concentration can be achieved together with a reduced diffusion
54
distance between mucosal surface and the absorption site connected to a high flux rate (6).
55
According to the underlying mechanisms of mucoadhesion, the mucoadhesive can interact with
56
mucus substructures, mainly glycoproteins (mucin), via on the one hand rather weak interactions
57
like ionic interactions, hydrogen bonds, van-der-Waals forces and hydrophobic interactions, or on
58
the other hand by forming strong covalent bonds (7). Thiomers can be regarded as the most
59
prominent representatives in the field of mucoadhesion, facilitating strong covalent bonding via
60
the formation of disulfide bonds with cysteine-rich mucin domains (8). Furthermore, disulfide
61
bonds can also be formed within the thiomer structure resulting in a highly cohesive polymeric
62
network (9, 10). One shortcoming of this intra- and inter-molecular cross-linking is the loss of
63
available reactive groups towards mucus glycoproteins accompanied by reduced chain flexibility
64
and mobility, preventing interpenetration of the mucus gel layer and finally ending up in weakness
65
of adhesive forces (11).
66
Therefore an alternative covalent binding mucoadhesive polymer type has been introduced in a
67
previous study of our research group omitting the above-mentioned susceptibility to self-cross-
68
linking. By covalent attachment of N-hydroxysuccinimide (NHS) to the polymeric backbone of
69
poly(acrylic acid) (PAA), amino reactive esters were generated with the objective to target amino
70
groups of lysine and arginine substructures of mucin glycoproteins (12, 13). Despite their 3 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 4 of 39
71
unfavorable rather hydrophobic character these polymer conjugates showed promising results
72
regarding mucoadhesive properties (14).
73
However, the mucoadhesive properties of such kind of polymeric NHS-esters has not been
74
evaluated in direct comparison to thiomers in order to specify the extent of potential pros and cons
75
of the two systems. Sulfo-NHS was used in this study instead of NHS by the idea of yielding esters
76
with higher hydrophilicity and improved mucoadhesive characteristics (15). It was therefore the
77
objective of this study to synthesize PAA derivatives with comparable amount of reactive groups
78
and to investigate their mucoadhesiveness via the rotating cylinder method and tensile studies.
79
Furthermore, dynamic viscosity measurements of polymer/mucus mixtures were performed to
80
allow the assessment of structural changes within the mucus gel network.
81
2. Materials and Methods
82
2.1. Materials
83
Dimethylformamide, acetonitrile and methanol were obtained from VWR chemicals (Radnor, PA,
84
USA).
85
hydroxysulfosuccinimide (Sulfo-NHS), L-cysteine hydrochloride, all buffers and salts were
86
purchased from Sigma-Aldrich (Vienna, Austria).
Poly(acrylic
acid)
450
kDa
(PAA),
N,N'-diisopropylcarbodiimide,
N-
4 ACS Paragon Plus Environment
Page 5 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
87
2.2. Methods
88
2.2.1. Synthesis of polymers
89
2.2.1.1.
90
Sulfo-NHS was attached to the polymeric backbone of PAA mediated by N,N'-
91
diisopropylcarbodiimide (DIC) as coupling reagent. First, 0.5 g of the polymer was dissolved in
92
dimethlylformamide (DMF) under stirring. Following, 1 mL of DIC and either 150 mg to
93
synthesize PAA-Sulfo-NHS 300 or 300 mg Sulfo-NHS in case of PAA-Sulfo-NHS 800 were
94
added. After 18 h stirring, the products were purified from any residual amounts of coupling
95
reagent, byproducts and DMF by several washing steps with acetonitrile and dried under vacuum.
96
2.2.1.2.
97
PAA-cysteine derivatives were synthesized in the same way as PAA-Sulfo-NHS, except for the
98
addition of L-cysteine HCl instead of Sulfo-NHS. In order to obtain different coupling rates,
99
219 mg (PAA-Cys 300) and 544 mg (PAA-Cys 800) of L-cysteine HCl were added to the reaction
100
mixture. Reaction time was kept at 18 h. Products were washed with acetonitrile and dried under
101
vacuum. Finally to separate unreacted L-cysteine from the polymers, washing with a mixture of
102
acetonitrile/methanol (10/1 (v/v)) was performed and the products dried. Poly(acrylic acid) only
103
treated with the solvents used in the syntheses was prepared as a control polymer for further
104
conducted experiments.
105
2.2.2. Characterization of polymers
106
Molecular mass of the newly synthesized PAA derivatives was estimated by static light scattering
107
with a Zetasizer Nano ZSP (Malvern, USA) with a laser wavelength of 633 nm at 25 °C. Polymers
108
were dissolved in a mixture of dimethyl sulfoxide/ 0.5 M NaCl 1:1. The refractive index increment
Synthesis of PAA-Sulfo-NHS
Synthesis of PAA-cysteine
5 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 6 of 39
109
(dn/dc = 0.147 mL/g) was determined using an Abbe refractometer ATAGO 1T equipped with an
110
ATAGO digital thermometer (ATAGO CO.,LTD., Japan).
111
Modification degree of PAA-Sulfo-NHS was determined by the detection of Sulfo-NHS bound to
112
the polymer after alkaline ester hydrolysis (16). Hence, 2 mg of PAA-Sulfo-NHS derivatives were
113
dissolved in 1 mL of 0.1 M NaOH followed by absorption measurement at 260 nm (TECAN
114
Infinite M200, Austria GmbH). Liberated Sulfo-NHS in the probes was quantified with respect to
115
a calibration curve being based on pure Sulfo-NHS.
116
FTIR spectra were taken from PAA, Sulfo-NHS, PAA-Sulfo-NHS 300 and PAA-Sulfo-NHS 800
117
using a Perkin Elmer Spectrum 100 ATR-IR spectrometer (Perkin Elmer, Waltham, MA) in an
118
arrangement with the software version 6.3.1.0134 (Perkin Elmer). Spectra were recorded with 10
119
scans in a wave number range from 4000 to 650 cm-1 and a resolution of 1 cm-1. Measurements
120
were performed at 22°C (17).
121
NMR spectroscopy was performed on a 400 MHz Bruker Advance equipped with a 1H-13C SEI
122
probe and the spectra were evaluated by TopSpin 3.5 pl 7 software. For the measurements 15 mg
123
of PAA, of Sulfo-NHS and of PAA-Sulfo-NHS were dissolved in D2O. 1H-NMR was recorded for
124
PAA, Sulfo-NHS and PAA-Sulfo-NHS and a 13C-NMR was additionally recorded for PAA-Sulfo-
125
NHS.
126
The amount of free thiol groups immobilized at the polymeric backbone of the conjugates was
127
determined photometrically (TECAN Infinite M200, Austria GmbH) using 5,5′-dithiobis (2-
128
nitrobenzoic acid) as described previously (11).
129
6 ACS Paragon Plus Environment
Page 7 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
130
2.2.3. Assessment of hydrolytic stability
131
Stability of the PAA-Sulfo-NHS conjugates was investigated in aqueous media. In brief, test
132
polymers were hydrated in either simulated gastric fluid (0.1 M HCl, pH 1.2) or phosphate buffer
133
100 mM pH 7.4 in a final concentration of 1 mg/mL. Subsequently, samples were incubated at
134
37 °C under shaking at 200 rpm. Aliquots of 120 µL were withdrawn at predefined time points,
135
centrifuged at 12,044 x g for 2 min and the supernatant analyzed for Sulfo-NHS content by
136
absorption measurement at 260 nm (TECAN Infinite M200, Austria GmbH). In the case of gastric
137
fluid pH was raised by the addition of 0.2 M phosphate buffer pH 7.4 in a ratio of 1:1 before
138
analyses as UV detection of Sulfo-NHS is only feasible when the molecule is present in the ionized
139
form (16). A Sulfo-NHS calibration curve was subjected to the same procedure.
140
2.2.4. Evaluation of toxicity
141
2.2.4.1.
142
Red blood cell lysis assay was carried out using a protocol previously described with slight
143
modifications (18). First, red blood cell concentrate was diluted 1/10 in phosphate buffered saline
144
(PBS). PAA conjugates were added to the cell dilution in final concentrations in the range of 0.05 %
145
to 0.5 % (m/v). As positive control resulting in total hemolysis served demineralized water and
146
PBS was taken as a negative control with 0 % cell lysis, respectively. Hemolysis was quenched
147
after 30 min incubation at 37 °C by putting the samples on ice for 2 min. After that the probes were
148
5 min centrifuged at 3000 rpm and the released hemoglobin in the supernatant detected at 540 nm
149
(TECAN Infinite M200, Austria GmbH).
Hemolysis assay
150
7 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 8 of 39
151
2.2.4.2.
Caco-2 cell assay
152
The cytotoxic potential of the PAA conjugates was examined on Caco-2 cells employing the
153
resazurin assay (19, 20). Briefly Caco-2 cells were seeded on a 24 well plate
154
(d = 2.5 × 104 cells/well; 500 µL per well) in minimum essential medium (MEM) supplemented
155
with 10 % (v/v) fetal calf serum (FCS) and penicillin/ streptomycin solution (100 units/ 0.1 mg/L)
156
and cultured for 1 week at 37 °C in an atmosphere of 5 % CO2 and 95 % relative humidity. During
157
the culture period the medium was changed every second day. Afterwards, cells were washed with
158
preheated phosphate buffered saline (PBS) and treated with 500 μL of the test solutions. PAA-
159
Sulfo-NHS esters were tested in a 0.5 % (m/v) concentration and PAA-Cys derivatives were
160
applied in 0.25 % and 0.5 % (m/v). MEM served as a negative and a 1 % (m/v) solution of Triton
161
X-100 as positive control. After an incubation time of 4 h cells were washed with PBS and a 5 %
162
(m/v) resazurin solution was added. The cells were incubated for additional 2 h and fluorescence
163
of the supernatant was measured at 540 nm excitation wavelength and 590 nm emission
164
wavelength (TECAN Infinite M200, Austria GmbH).
165
2.2.5. Preparation of polymer test discs
166
Within the executed swelling test and mucoadhesion experiments, polymers were used in the form
167
of compacted discs. For this purpose each polymer was compressed into flat faced discs of 30 mg
168
and 5.0 mm diameter using a single punch excentric press (Paul Weber, Remshalden-Grünbach,
169
Germany). The applied pressure during disc manufacturing was kept constant at 11 kN for a
170
duration of 30 seconds. Test discs were stored in a dessicator until further use.
171
8 ACS Paragon Plus Environment
Page 9 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
172
2.2.6. Assessment of swelling behavior
173
Water uptake was investigated and as a result of this the swelling behavior of the polymer discs
174
evaluated by determining their mass increase gravimetrically as described previously (11).
175
Accordingly, discs were fixed with a metal clamp and submerged into preheated phosphate buffer
176
100 mM pH 7.4 and incubated at 37 °C. Discs were taken out of the buffer at predetermined time
177
points and weighed.
178
2.2.7. Evaluation of mucoadhesive properties
179
2.2.7.1.
180
The retention time of polymer discs attached to freshly excised porcine intestinal mucosal tissue,
181
was evaluated using the rotating cylinder method as described in previous studies of our research
182
group (21). In brief, the mucosa was glued on a stainless steel cylinder using a cyanoacrylate
183
adhesive (Locite, Henkel, Austria) and test discs were attached to the mucosal surface. Afterwards,
184
the cylinder was placed in a dissolution tester (Erweka GmbH, Heusenstamm, Germany) according
185
to the European Pharmacopeia, immersed into 900 mL of a 100 mM phosphate buffer pH 7.4 and
186
rotated at a speed of 100 rpm at 37 °C. Detachment of the polymer discs was observed visually.
187
2.2.7.2.
188
Tensile studies were performed using a texture analyser (TA.XTPlus, Texture Analyser Stable
189
Micro Systems, Winopal Forschungsbedarf GmbH, Elze, Germany) equipped with A/MUC
190
mucoadhesive rig fixture. Briefly, the mucosa was cut into pieces of approximately 2 cm2 and was
191
fixed between two acrylic glass plates and the polymeric test disc was applied to a probe cylinder
192
(P/05, ½” Delrin Cylinder) with a double-sided adhesive tape. Polymer and mucosal surface were
193
put in contact by lowering the probe cylinder. Subsequently this contact stage was kept for a 20 min
Rotating cylinder
Tensile force measurement
9 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 10 of 39
194
incubation time under a constant applied force of 0.01 N. After incubation, the polymer was pulled-
195
up with a speed of 0.1 mm/s until the disc was completely detached from the tissue. The maximum
196
detachment force (MDF) and the total work of adhesion (TWA) were calculated from the recorded
197
measurement data.
198
2.2.8. Mucus collection
199
Fresh porcine intestine fetched from a local abattoir was cut longitudinally and rinsed carefully
200
with physiological saline (NaCl 0.9 % (m/v)) to remove all food remains. Afterwards the mucus
201
was collected by gently scrapping it off from the underlying tissue. The water content of mucus
202
was 78.8 ± 0.2 % (m/m), determined gravimetrically. Rheological measurements using a plate-
203
plate viscometer (RotoViscoTM 158 RT20, Haake GmbH, Karlsruhe, Germany) at a frequency of
204
1 Hz and a sheer stress range of 0.01 Pa–50 Pa yielded a dynamic viscosity of 0.64 ± 0.05 Pas.
205
2.2.9. Rheological investigations
206
Dynamic viscosity measurements were performed with a plate-plate viscometer (RotoViscoTM
207
158 RT20, Haake GmbH, Karlsruhe, Germany) at 37 °C, a frequency of 1 Hz and a sheer stress
208
range of 0.01 Pa–50 Pa. Therefore, test samples were prepared by adding the dry polymer in a final
209
concentration of 1 % (m/m) to a porcine mucus/ buffer (100 mM phosphate buffer, pH 7.4) mixture
210
(5/1). After incubation times of 5 min, 30 min and 120 min, samples were transferred to the plate
211
of the viscometer and the dynamic viscosity was measured.
10 ACS Paragon Plus Environment
Page 11 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
212
2.2.10. Statistical data analysis
213
The software Graph Pad Prism version 5.01 was used for the statistical data analysis. One way
214
ANOVA and Bonferroni t-test were performed with P < 0.05 as the minimal level of significance.
215
3. Results and discussion
216
3.1. Synthesis and characterization of polymers
217
Sulfo-NHS was used in this study in order to yield products with higher solubility than NHS
218
analogues by possessing the same specificity and reactivity (15). As the reactive esters are highly
219
sensitive to hydrolysis, PAA-Sulfo-NHS conjugates were synthesized in a water free environment
220
in order to avoid premature cleavage of the formed ester bond. In virtue of comparability, PAA-
221
Cys was generated under similar conditions (Figure 1). Derivatives with two different coupling
222
rates were obtained by varying the amounts of Sulfo-NHS and L-cysteine in reaction mixtures.
223
Efficiency of the ester bond formation can be considered as higher compared to amide bond
224
formation of PAA-Cys, as lower molar ratios of ligand to polymer were sufficient to obtain a
225
comparable coupling rate (Table 1).
226
11 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 12 of 39
227 228 229 230
Figure 1: Reaction scheme of carbodiimide mediated syntheses. PAA-Sulfo-NHS (A) was built via ester bond formation between PAA and Sulfo-NHS. PAA-Cys (B) was synthesized via covalent attachment of L-cysteine to the polymer resulting in an amide bond.
231 232 233 234 235
Table 1: Amounts of attached reactive groups at the polymeric backbone of polyacrylic acid dependent on the used weighed portions in the syntheses. Data are illustrated in form of mean values of at least three measurements including standard deviation. Polymer
PAASulfo-NHS 300 PAASulfo-NHS 800 PAA-Cys 300 PAA-Cys 800
Synthesis amounts [mol] PAA LSulfocysteine NHS 1.0 0.1
-Sulfo-NHS [µmol/g] Mean SD
-SH [µmol/g] Mean
SD
363.0
76.8
-
-
1.0
-
0.2
885.5
89.0
-
-
1.0
0.2
-
-
-
326.3
73.4
1.0
0.5
-
-
-
815.3
18.2
236 12 ACS Paragon Plus Environment
Page 13 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
237
Static light scattering experiments revealed an average molecular mass of 412 ± 43.0 kDa for PAA-
238
Sulfo-NHS 300 and 490 ± 14.8 kDa for PAA-Sulfo-NHS 800. In case of the PAA control a
239
molecular mass of 353 ± 14.9 kDa was detected.
240
Upon alkaline hydrolysis of PAA-Sulfo-NHS, Sulfo-NHS could be quantified at 260 nm and the
241
attached amount of ligand was calculated. Free thiol groups immobilized on the backbone of PAA
242
were determinated by Ellman´s assay.
243
Successful formation of the PAA-Sulfo-NHS conjugate was additionally to UV detection
244
confirmed by FTIR spectroscopy (spectra are presented in the supporting information in Figure S1-
245
S3). Polyacrylic acid displayed the typical C-H stretching vibrations at about 2941 cm-1. The
246
carboxyl group was characterized by a wide OH stretch from 3176 to 2583 cm-1, which
247
superimpose the C-H stretching bands. The C=O stretch of carboxylic acid appeared at 1699 cm- 1,
248
those of C-O exist at 1232 cm-1. In the spectrum of Sulfo-NHS characteristic bands were at
249
3149 cm-1 (O-H), 3005 cm-1 to 2934 cm-1 (C-H), 1702 cm-1 (C=O). The PAA-Sulfo-NHS
250
spectrum showed a reduction of the broad OH band, being an indicator for esterification of COOH
251
groups with Sulfo-NHS. Esterification led to characteristic carbonyl bands at 1734 cm-1. Another
252
indication for the formation is the disappearing of the characteristic carbonylfinger band of the acid
253
group at 1700 cm-1. Furthermore, amide I bands were detectable at 1614 (22). Rising of a new peak
254
at 3338 cm-1 could not be associated to characteristic group signals according to literature.
255
The formation of PAA-Sulfo-NHS was furthermore characterized via NMR- spectroscopy
256
(supporting information Figure S4-S7). The 1H-NMR spectra of PAA-Sulfo-NHS in D2O shows
257
the typical peaks at 1.60 – 2.0 ppm for the CH2-group and at 2.44 ppm for the methine-group of
258
PAA and the geminale peaks corresponding to the CH2 group at 3.06 and 3.27 ppm as well the dd
259
at 4.35 ppm of N-hydroxysulfosuccinimide. The small shift of 0.20 ppm of the CH2- and the 13 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 14 of 39
260
methine-group in corresponding to the NMR spectra of PAA (see supporting information) into the
261
downfield evidenced the esterification of PAA and Sulfo-NHS.
262
3.2. Assessment of hydrolytic stability
263
Although the polymers were mainly used in dry form within the experiments focusing on adhesive
264
properties, the reactivity in hydrated form is important. As the stability of reactive thiol groups on
265
polymers has already been described in literature (23), stability of PAA-Cys derivatives was not
266
further evaluated. NHS ester stability is reported in literature with half-lives ranging between
267
1 hour at pH 8 and 25 °C (23) and 10 min at 8.6 at 4 °C (24) with higher hydrolytic stability at
268
pH 5 and 6 (25). Along pH and temperature, hydrolysis of hydrophilic esters is strongly dependent
269
on the hydration behavior of the polymer backbone. Ester hydrolysis was therefore investigated in
270
more detail. Visual observations confirmed complete hydration of the polymers within less than
271
30 min. Consequently, ester hydrolysis happened fast under both applied pH conditions with a half-
272
life of around 17.5 min (PAA-Sulfo-NHS 300) and 8 min (PAA-Sulfo-NHS 800) at pH 1.2 and 7-8
273
min for both modifications at pH 7.4 (Figure 2). The total amount of Sulfo-NHS having been
274
hydrolytically cleaved at pH 1.2 and 7.4 correlated to the amount of covalently attached Sulfo-
275
NHS as listed in Table 1.
14 ACS Paragon Plus Environment
Page 15 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
276 277 278 279
Figure 2: Time dependent ester hydrolysis in 0.1 M HCl (A) and 100 mM phosphate buffer pH 7.4 (B). Illustrated values are means of at least three experiments ± standard deviation. PAA-SulfoNHS 300 (■) and PAA-Sulfo-NHS 800 (▲).
280
3.3. Evaluation of toxicity
281
As Sulfo-NHS ester structures are frequently used for the labeling of cell surface proteins, PAA-
282
Sulfo-NHS polymers might show a damaging effect to the cell membrane (15, 26). In vitro
283
erythrocyte lysis can be considered as a valid test to predict membrane damaging effects of the test
284
compounds in vivo. As cell membrane rupture correlates with cytotoxicity in general, the
285
experimental set-up can also be used to assess the polymer safety (18). Hemolysis was calculated
286
as a percentage of the 100 % lysis value (Figure 3). According to the ASTMF756-00(2000)
287
standard, materials with hemolysis rates greater than 5 % are regarded as hemolytic. Except of 15 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 16 of 39
288
PAA-Sulfo-NHS 800 at a concentration of 0.5 % (m/v) all other tested polymer concentrations did
289
not possess any hemolytic potential. When subtracting the negative control from the sample values,
290
hemolysis deriving from the pure polymer was 6.3 ± 0.4 %. One explanation for this finding might
291
be the afore mentioned possible covalent binding of PAA via amide bond formation to cell surface
292
proteins, ending up in membrane interference and cell damage. Sulfo-NHS alone did not induce
293
any noticeable erythrocyte lysis in a concentration corresponding to the amount maximal included
294
in a 0.5 % test solution of PAA-Sulfo-NHS 800. PAA-Cys conjugates induced hemolysis in the
295
range of 0.4 % for PAA-Cys 300 and PAA-Cys 800 in 0.5 % (m/v) concentration, and 0.1 %
296
hemolysis for PAA-Cys 300 in 0.05 % (m/v). Additionally cell permeation and systemic uptake of
297
PAA-Sulfo-NHS and pure Sulfo-NHS seem to be unlikely due to the negative charge of the
298
sulfonate group (27). Summarizing, harmful effects of both modified polymer types on the cell
299
membrane can be widely excluded. Nevertheless, cytotoxicity was studied on Caco-2 cells (Figure
300
4). Sulfo-NHS esters did not evoke any toxic effect, whereas the thiolated polymers displayed a
301
concentration dependent effect on cells. These findings can be explained by a primarily physical
302
effect caused by a layer of completely swollen polymer settled on the surface of the cell monolayer,
303
hindering the access of nutrients and oxygen. In vivo the polymer will likely not get into contact
304
with the mucosal membrane in such high concentration because of limited diffusion across the
305
mucus layer. Moreover PAA-Cys derivatives can be considered as generally safe as their
306
innocuousness could even be proven within a clinical study applied on the sensitive mucosal
307
surface of the eye (28).
16 ACS Paragon Plus Environment
Page 17 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
308 309 310 311
Figure 3: Percentage of hemolysis caused by the controls, Sulfo-NHS and different concentrations of the PAA-Sulfo-NHS and PAA-Cys conjugates. Values represent data of at least three replications plus standard deviation.
17 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 18 of 39
312 313 314 315 316
Figure 4: Percentage of Caco-2 cell viability caused by the controls, PAA-Sulfo-NHS derivatives in 0.5 % (m/v) (A) and PAA-Cys conjugates (B) in 0.25 % (m/v) (light gray) and 0.5 % (m/v) (dark gray). Cells were incubated for 4 h. Values represent data of at least three replications plus standard deviation.
317
3.4. Assessment of swelling behavior
318
A sufficient amount of swelling is necessary to properly hydrate the polymer and expose available
319
adhesive sites for bond formation. Therefore, the capacity of water uptake was investigated by
320
monitoring the percentage of mass increase over time (Figure 5). PAA-Cys discs exhibited a high
321
water uptake capacity and moreover polymer dissolution in comparison to the PAA control was
322
retarded. During the first 45 min, PAA-Cys conjugates possessed similar water uptake, compared 18 ACS Paragon Plus Environment
Page 19 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
323
to PAA. Maximum swelling was reached after 180 min with around 400 % of the initial disc weight
324
for PAA-Cys 300 and PAA-Cys 800 completed swelling after 420 min by 960 % mass increase.
325
This observation can be explained by the formation of intra polymeric disulfide bridges,
326
contributing to a highly cohesive structure with a high water uptake capacity. In contrast, the
327
behavior of PAA-Sulfo-NHS was strikingly different, as discs were slightly swelling. PAA-Sulfo-
328
NHS 300 was about 3.1-fold and PAA-Sulfo-NHS 800 around 2.3-fold less swelling than the PAA
329
control, and the polymers rather start dissolving after 30 to 45 min. This fast dissolution can be
330
explained by the hydrophilicity of the sulfonate group, favoring additional to the carboxylic groups
331
on the PAA backbone, strong hydrogen bonding with water molecules followed by fast
332
disentanglement of the single polymer chains.
333
19 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 20 of 39
334
335 336 337 338 339
Figure 5: Time dependent water uptake of polymer discs in 100 mM phosphate buffer pH 7.4. Illustrated values are means of at least three experiments ± standard deviation. A: PAA control (●), PAA-Sulfo-NHS 300 (■) and PAA-Sulfo-NHS 800 (▲). B: PAA control (●), PAA-Cys 300 (■) and PAA-Cys 800 (▲).
20 ACS Paragon Plus Environment
Page 21 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
340
3.5. Evaluation of mucoadhesive properties
341
3.5.1. Rotating cylinder
342
Within this study adhesive as well as cohesive properties of polymer discs can be evaluated. Along
343
with the direct interactions of the polymer and mucus layer, the test material´s cohesiveness
344
furthermore prolongs the retention time on the mucosa. Due to the modification, adhesion time of
345
PAA-Sulfo-NHS 300 was 2.5-fold increased and a higher modification led to a 2.9-fold increase
346
for PAA-Sulfo-NHS 800 respectively (Figure 6). Having a closer look at the mechanism of
347
covalent bond formation, the dependence on the environmental pH has to be taken into
348
consideration in order to explain the findings. Amide bond formation between Sulfo-NHS esters
349
and primary amino groups has its pH optimum in a range of 7 to 9. Within a previous study,
350
reactivity towards glycine and hence adhesion to mucus was already established under
351
physiological pH for PAA-NHS esters (14). Accordingly, it can be assumed that PAA-Sulfo-NHS
352
will likely react in the same way under the formation of a powerful mucoadhesive junction. Thiol
353
groups tend to continuous oxidation at pH values above 5. Within the buffer pH 7.4 intra- and inter
354
polymeric disulfide bridges can easily be formed additionally to fast covalent binding to the
355
mucosa. As opposed to the Sulfo-NHS conjugates, a highly cohesive polymer network was built
356
and the adhesion time was on account of this additively extended by 5.3-fold (PAA-Cys 300) and
357
7.9-fold (PAA-Cys 800) compared to unmodified PAA. Observations were in good agreement with
358
the results of the water uptake study, as a fast dissolution of PAA-Sulfo-NHS and excessive
359
swelling of PAA-Cys could be confirmed.
21 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 22 of 39
360 361 362 363 364
Figure 6: Mucoadhesive properties of PAA, PAA-Sulfo-NHS 300, PAA-Sulfo-NHS 800, PAACys 300 and PAA-Cys 800. The time of adhesion on freshly excised porcine intestinal mucosa was determined via the rotating cylinder method in 100 mM phosphate buffer pH 7.4. The graph shows the means of at least three experiments ± standard deviation (***P < 0.001).
365
3.5.2.Tensile force measurement
366
Tensile studies rank among the most established and used mucoadhesive test systems. In general,
367
the higher the mucoadhesion of polymer, the higher are the resulting maximum detachment force
368
and total work of adhesion. Both types of PAA derivatives exhibited higher adhesive forces,
369
leading to increased MDF and TWA values compared to the control (Figure 7). The maximum
370
detachment force reflects the strength of the covalent bond formed between polymer and mucus,
371
whereas the total work of adhesion represents the total energy needed to completely detach the
372
polymer from the mucosa. The improvements in case of MDF were 2.7-fold (PAA-Sulfo-
373
NHS 300), 2.3-fold (PAA-Sulfo-NHS 800 and PAA-Cys 300) and 2.0-fold (PAA-Cys 800),
374
respectively. Upon modification stated enhancements in TWA were 7.6-fold (PAA-Sulfo-
375
NHS 300), 6.9-fold (Sulfo-NHS 800), 3.0-fold (PAA-Cys 300) and 3.6-fold (PAA-Cys 800)
376
compared to the unmodified PAA control. Interestingly, the recorded MDF and TWA were higher 22 ACS Paragon Plus Environment
Page 23 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
377
for the Sulfo-NHS derivatives, especially when comparing the higher modified polymers. Taking
378
the results of the water uptake study and rotating cylinder into consideration, mentioned distinct
379
differences might be explained by different performances regarding cohesiveness and dissolution.
380
Fast swelling ability of thiomers promotes the formation of a highly stable and cohesive cross-
381
linked polymeric network. Accompanied by high cross-linking within the PAA-Cys structure,
382
possible shortcomings could be a decreased amount of free thiol groups needed for covalent
383
binding to mucins on the one hand, resulting in lower MDF, and on the other hand overhydrating
384
of the polymer could provide a slippery mucilage, and thus consequential reduce TWA (6, 7). The
385
high dissolution rate of the PAA-Sulfo-NHS derivatives favors disentanglement of the polymeric
386
network. In the space of a previous study, interpenetration of loose polymeric chains into the mucin
387
network was pointed out as one of the key features influencing mucoadhesion (29). Based on the
388
higher molecular mobility and flexibility of the polymer, non-cross-linked polymers like PAA-
389
Sulfo-NHS, should be able to interpenetrate the mucus gel layer more deeply giving rise to
390
enhanced adhesion forces (30). The existing pH gradient of mucus from the luminal side (pH 5.5)
391
to the apical side (pH 7.4), combined with the pH optima of the covalent bond formation is
392
supporting that theory. As a result, it can be suspected that Sulfo-NHS esters are diffusing the
393
mucus mesh more deeply before they react and thiomers stay rather at the surface of the mucus
394
layer. In contrast to the amide bond, disulfide bonds are reversible under physiological conditions
395
as they can be reduced by glutathione within the mucus. Consequently disulfide bonds might be
396
less stable resulting in lower adhesion forces.
397
In comparison to the PAA-NHS ester of the previous work, with comparable amount of reactive
398
groups (data not shown), stronger adhesive forces were measured upon modification with Sulfo-
399
NHS resulting in an additional 1.4-fold improvement of MDF and a 2.6-fold enhancement of TWA
400
(14). 23 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 24 of 39
401 402 403 404 405
Figure 7: The graphs display the mucoadhesive properties of PAA, PAA-Sulfo-NHS 300, PAASulfo-NHS 800, PAA-Cys 300 and PAA-Cys 800 determined via tensile studies. Figure part A shows the maximum detachment force (MDF) and B the total work of adhesion (TWA). Values are means ± standard deviation of at least three experiments (***P < 0.001).
406
3.6. Rheological investigations
407
Rheological measurements can provide information about the structure of the polymer-mucin
408
network. Increasing viscosity of mucus/polymer mixtures in comparison to the control can be
409
explained by the interactions between the mucus gel network and the polymer molecules. Sufficient 24 ACS Paragon Plus Environment
Page 25 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
410
depth of polymer chain interpenetration with mucins is a crucial requirement for physical
411
entanglement, conformational changes and secondary chemical interactions (6). Main occurring
412
chemical interactions are non-covalent ones like ionic interactions, hydrogen bonding, van-der-
413
Waals forces and covalent bonds as disulfide or amide bonds. Thiomers are able to build a strong
414
three-dimensional network by the formation of disulfide bridges with cysteine-rich subdomains of
415
the mucus glycoproteins (9). According to the theory PAA-Sulfo-NHS esters should also be able
416
to covalently bind to arginine or lysine mucin substructures via amide bond formation. Upon
417
formation of adhesive joints, gel strengthening can occur together with increased resistance to
418
elastic deformation (7).
419
Thus after 2 h incubation time the viscosity of polymer/mucus mixtures increased significantly,
420
except for the PAA control (Figure 8). Beside weak hydrogen bonds, PAA is not forming a covalent
421
network with the mucus and adhesive interactions can only occur to a minor extent. Depending on
422
the degree of modification the viscosity of the samples increased, pointing out the building of gel-
423
like structures. Dynamic viscosity increased up to 2.6-fold (PAA-Sulfo-NHS 300), 10.8-fold
424
(PAA-Sulfo-NHS 800), 10.3-fold (PAA-Cys 300) and 20.7-fold (PAA-Cys 800), respectively.
425
In case of thiomers, the recorded rheological synergism is not only attributed to polymer-mucin
426
interactions, rather the occurrence of intramolecular oxidation under physiological conditions
427
additionally enhances in situ gelling, explaining the higher values in total dynamic viscosity
428
compared to those of the PAA-Sulfo-NHS samples. Unlike thiomers, PAA-Sulfo-NHS esters are
429
not building intramolecular cross-links and the determined extent of increase in viscosity is only
430
caused by direct interactions between polymer and mucin via physical entanglement together with
431
amide bond formation.
25 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 26 of 39
432
Attributed to the replacement of NHS by the more hydrophilic Sulfo-NHS, a further 2.3-fold
433
increase in viscosity could be achieved after 2 h incubation. This finding might be explained by
434
virtue of additional non-covalent bindings like ionic interactions between the charged sulfonate
435
group and mucin substructures, or hydrogen bonds (14).
436 437 438 439 440 441 442
Figure 8: Comparison of the dynamic viscosity of the PAA conjugates with intestinal porcine mucus after different time of incubation. Polymers were incubated in a final concentration of 1 % (m/m) in mucus/buffer (100 mM phosphate buffer pH 7.4) mixtures (5/1) at 37 °C. White bars represent the PAA control, light grey bars show the lower modification and dark grey stands for the high modification degree. Figure part A displays results for PAA-Sulfo-NHS and part B illustrates the data of the PAA-Cys derivatives.
443
26 ACS Paragon Plus Environment
Page 27 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
444
4. Conclusion
445
Within this study a new type of mucoadhesive covalently binding polymers was compared to
446
thiomers. Both modifications resulted in improved adhesive forces on porcine intestinal mucosa
447
compared to the unmodified polyacrylic acid and furthermore rheological synergism could be
448
confirmed. As a result of the replacement of NHS by Sulfo-NHS, more hydrophilic conjugates
449
could be obtained with the advantage of increased tensile forces and advanced rheological
450
synergism. The major shortcoming induced by the highly hydrophilic character of PAA-Sulfo-
451
NHS derivatives is their high dissolution rate, what makes it difficult to act as a proper drug
452
delivery matrix as strong mucoadhesive joints alone will not do the job. In contrast, thiomers are
453
able to build a stable, cross-linked, highly cohesive intramolecular polymeric network beside
454
covalent disulfide bond formation to mucins upon oxidation under physiological conditions.
455
Hence, a diffusion controlled release of an incorporated drug is possible. In conclusion, thiomers
456
seem to be more advantageous, as disulfide bonds can be regarded as the most important bridging
457
structure in mucus and copying nature seems to be effective in order to generate powerful drug
458
delivery excipients.
459
Associated Content
460
Supporting Information
461
IR and 1H-NMR spectra of educts and PAA-Sulfo-NHS polymer.
462
Sulfo-NHS.
13C-NMR
spectrum of PAA-
463
27 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 28 of 39
464
Acknowledgments
465
The Austrian Research Promotion Agency FFG [West Austrian BioNMR 858017] is kindly
466
acknowledged.
467
Reference
468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497
1. Caramella C, Bonferoni MC, Rossi S, Ferrari F. Rheological and tensile tests for the assessment of polymer-mucin interactions1994. 213-7 p. 2. Smart JD, Kellaway IW, Worthington HE. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. The Journal of pharmacy and pharmacology. 1984;36(5):295-9. 3. Grabovac V, Guggi D, Bernkop-Schnürch A. Comparison of the mucoadhesive properties of various polymers. Advanced drug delivery reviews. 2005;57(11):1713-23. 4. Albarkah YA, Green RJ, Khutoryanskiy VV. Probing the Mucoadhesive Interactions Between Porcine Gastric Mucin and Some Water-Soluble Polymers. Macromolecular bioscience. 2015;15(11):1546-53. 5. Martins ALL, de Oliveira AC, do Nascimento CMOL, Silva LAD, Gaeti MPN, Lima EM, et al. Mucoadhesive Properties of Thiolated Pectin-Based Pellets Prepared by Extrusion-Spheronization Technique. Journal of pharmaceutical sciences. 2017;106(5):1363-70. 6. Madsen F, Eberth K, Smart JD. A rheological examination of the mucoadhesive/mucus interaction: the effect of mucoadhesive type and concentration. Journal of controlled release : official journal of the Controlled Release Society. 1998;50(1-3):167-78. 7. Smart JD. The basics and underlying mechanisms of mucoadhesion. Advanced drug delivery reviews. 2005;57(11):1556-68. 8. Shen J, Wang Y, Ping Q, Xiao Y, Huang X. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. Journal of Controlled Release. 2009;137(3):217-23. 9. Bernkop-Schnürch A. Thiomers: a new generation of mucoadhesive polymers. Advanced drug delivery reviews. 2005;57(11):1569-82. 10. Gök MK, Demir K, Cevher E, Özsoy Y, Cirit Ü, Bacınoğlu S, et al. The effects of the thiolation with thioglycolic acid and l-cysteine on the mucoadhesion properties of the starch-graft-poly(acrylic acid). Carbohydrate polymers. 2017;163:129-36. 28 ACS Paragon Plus Environment
Page 29 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537
Molecular Pharmaceutics
11. Marschütz MK, Bernkop-Schnürch A. Thiolated polymers: selfcrosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2002;15(4):387-94. 12. Yan JX, Packer NH. Amino Acid Analysis of Mucins. In: Corfield AP, editor. Glycoprotein Methods and Protocols: The Mucins. Totowa, NJ: Humana Press; 2000. p. 113-9. 13. Nanda JS, Lorsch JR. Labeling a protein with fluorophores using NHS ester derivitization. Methods in enzymology. 2014;536:87-94. 14. Menzel C. How to avoid syringes by mucosal drug delivery : addressing the mucus gel layer [Dissertation]: University of Innsbruck; 2018. 15. Staros JV. N-hydroxysulfosuccinimide active esters: bis(Nhydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry. 1982;21(17):3950-5. 16. Miron T, Wilchek M. A spectrophotometric assay for soluble and immobilized N-hydroxysuccinimide esters. Analytical biochemistry. 1982;126(2):433-5. 17. Schonbichler SA, Bittner LK, Pallua JD, Popp M, Abel G, Bonn GK, et al. Simultaneous quantification of verbenalin and verbascoside in Verbena officinalis by ATR-IR and NIR spectroscopy. Journal of pharmaceutical and biomedical analysis. 2013;84:97-102. 18. Mahmoud DB, Shukr MH, Bendas ER. In vitro and in vivo evaluation of self-nanoemulsifying drug delivery systems of cilostazol for oral and parenteral administration. International journal of pharmaceutics. 2014;476(1-2):60-9. 19. Jennings P, Koppelstaetter C, Aydin S, Abberger T, Wolf AM, Mayer G, et al. Cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol. 2007;293(3):F831-8. 20. O'Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000;267(17):5421-6. 21. Bernkop-Schnürch A, Steininger S. Synthesis and characterisation of mucoadhesive thiolated polymers. International journal of pharmaceutics. 2000;194(2):239-47. 22. Martínez-Mancera FDea. Derivatzation and spectroscopic characterization of a biopolymer based on L-lysine with D-biotin analogs: copoly(L-lysine)-graft-(E-N-[X-D-biotinyl]-L-lysine). Química Nova. 2015;39(1):44-8. 29 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559
Page 30 of 39
23. Staros JV, Wright RW, Swingle DM. Enhancement by Nhydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Analytical biochemistry. 1986;156(1):220-2. 24. Cuatrecasas P, Parikh I. Adsorbents for affinity chromatography. Use of N-hydroxysuccinimide esters of agarose. Biochemistry. 1972;11(12):2291-9. 25. Mattson G, Conklin E, Desai S, Nielander G, Savage MD, Morgensen S. A practical approach to crosslinking. Molecular Biology Reports. 1993;17(3):167-83. 26. Elia G. Biotinylation reagents for the study of cell surface proteins. PROTEOMICS. 2008;8(19):4012-24. 27. Staros JV. N-hydroxysulfosuccinimide active esters: bis(Nhydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry. 1982;21(17):3950-5. 28. Hornof M, Weyenberg W, Ludwig A, Bernkop-Schnürch A. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. Journal of Controlled Release. 2003;89(3):419-28. 29. Imam ME, Hornof M, Valenta C, Reznicek G, Bernkop-Schnürch A. Evidence for the interpenetration of mucoadhesive polymers into the mucous gel layer. Stp Pharma Sciences. 2003;13(3):171-6. 30. Duchene D, Ponchel G. Principle and investigation of the bioadhesion mechanism of solid dosage forms. Biomaterials. 1992;13(10):709-14.
560
30 ACS Paragon Plus Environment
Page 31 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
88x66mm (300 x 300 DPI)
ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Figure 1: Reaction scheme of carbodiimide mediated syntheses. PAA-Sulfo-NHS (A) was built via ester bond formation between PAA and Sulfo-NHS. PAA-Cys (B) was synthesized via covalent attachment of L-cysteine to the polymer resulting in an amide bond. 177x126mm (300 x 300 DPI)
ACS Paragon Plus Environment
Page 32 of 39
Page 33 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
Figure 2: Time dependent ester hydrolysis in 0.1 M HCl (A) and 100 mM phosphate buffer pH 7.4 (B). Illustrated values are means of at least three experiments ± standard deviation. PAA-Sulfo-NHS 300 (■) and PAA-Sulfo-NHS 800 (▲). 82x118mm (300 x 300 DPI)
ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Figure 3: Percentage of hemolysis caused by the controls, Sulfo-NHS and different concentrations of the PAA-Sulfo-NHS and PAA-Cys conjugates. Values represent data of at least three replications plus standard deviation. 104x100mm (300 x 300 DPI)
ACS Paragon Plus Environment
Page 34 of 39
Page 35 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
Figure 4: Percentage of Caco-2 cell viability caused by the controls, PAA-Sulfo-NHS derivatives in 0.5 % (m/v) (A) and PAA-Cys conjugates (B) in 0.25 % (m/v) (light gray) and 0.5 % (m/v) (dark gray). Cells were incubated for 4 h. Values represent data of at least three replications plus standard deviation. 82x133mm (300 x 300 DPI)
ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Figure 5: Time dependent water uptake of polymer discs in 100 mM phosphate buffer pH 7.4. Illustrated values are means of at least three experiments ± standard deviation. A: PAA control (●), PAA-Sulfo-NHS 300 (■) and PAA-Sulfo-NHS 800 (▲). B: PAA control (●), PAA-Cys 300 (■) and PAA-Cys 800 (▲). 82x133mm (300 x 300 DPI)
ACS Paragon Plus Environment
Page 36 of 39
Page 37 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
Figure 6: Mucoadhesive properties of PAA, PAA-Sulfo-NHS 300, PAA-Sulfo-NHS 800, PAA-Cys 300 and PAACys 800. The time of adhesion on freshly excised porcine intestinal mucosa was determined via the rotating cylinder method in 100 mM phosphate buffer pH 7.4. The graph shows the means of at least three experiments ± standard deviation (***P < 0.001). 82x78mm (300 x 300 DPI)
ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Figure 7: The graphs display the mucoadhesive properties of PAA, PAA-Sulfo-NHS 300, PAA-Sulfo-NHS 800, PAA-Cys 300 and PAA-Cys 800 determined via tensile studies. Figure part A shows the maximum detachment force (MDF) and B the total work of adhesion (TWA). Values are means ± standard deviation of at least three experiments (***P < 0.001). 82x152mm (300 x 300 DPI)
ACS Paragon Plus Environment
Page 38 of 39
Page 39 of 39 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
Figure 8: Comparison of the dynamic viscosity of the PAA conjugates with intestinal porcine mucus after different time of incubation. Polymers were incubated in a final concentration of 1 % (m/m) in mucus/buffer (100 mM phosphate buffer pH 7.4) mixtures (5/1) at 37 °C. White bars represent the PAA control, light grey bars show the lower modification and dark grey stands for the high modification degree. Figure part A displays results for PAA-Sulfo-NHS and part B illustrates the data of the PAA-Cys derivatives. 82x123mm (300 x 300 DPI)
ACS Paragon Plus Environment